NCT03967808 French Renal Epidemiology and Information Network (REIN) Registry
| NCT ID | NCT03967808 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Central Hospital, Nancy, France |
| Condition | End-stage Renal Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2001-01 |
| Primary Completion | 2050-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,000 participants in total. It began in 2001-01 with a primary completion date of 2050-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Renal Epidemiology and Information Network (REIN) Registry was created in 2002 (after study pilot in 2001) to contribute to the development and evaluation of health strategies aiming at improving prevention and management of end-stage renal disease, and promoting clinical and epidemiological research in this field. It relies on a network of nephrologists, epidemiologists, patients and public health representatives, coordinated regionally and nationally.
Eligibility Criteria
Inclusion Criteria: * All patients with end stage renal disease on renal replacement therapy Exclusion Criteria: * Patients with acute renal failure ( i.e. those who recover all or some renal function within 45 days or are considered as such by experts when they die before 45 days) * Patient's refusal
Contact & Investigator
Carole Ayav, MD
✉ c.ayav@chru-nancy.frEmmanuelle Laurain, MD
PRINCIPAL INVESTIGATOR
Central Hospital, Nancy, France
Frequently Asked Questions
Who can join the NCT03967808 clinical trial?
This trial is open to participants of all sexes, studying End-stage Renal Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03967808 currently recruiting?
Yes, NCT03967808 is actively recruiting participants. Contact the research team at c.ayav@chru-nancy.fr for enrollment information.
Where is the NCT03967808 trial being conducted?
This trial is being conducted at Nancy, France.
Who is sponsoring the NCT03967808 clinical trial?
NCT03967808 is sponsored by Central Hospital, Nancy, France. The principal investigator is Emmanuelle Laurain, MD at Central Hospital, Nancy, France. The trial plans to enroll 6,000 participants.